FDA Inspection 1314092 — CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
The FDA completed an inspection of CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. on April 9, 2026 in Shijiazhuang. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 9, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Shijiazhuang (China)